180 related articles for article (PubMed ID: 33206504)
21. A case of acute promyelocytic leukaemia with unusual cytological features and a ZBTB16-RARA fusion gene.
Lechevalier N; Dulucq S; Bidet A
Br J Haematol; 2016 Aug; 174(4):502. PubMed ID: 27302179
[No Abstract] [Full Text] [Related]
22. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
Dong S; Tweardy DJ
Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
[TBL] [Abstract][Full Text] [Related]
23. Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein.
Jansen JH; Löwenberg B
Semin Hematol; 2001 Jan; 38(1):37-41. PubMed ID: 11172538
[TBL] [Abstract][Full Text] [Related]
24. The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L.
Hao BB; Li XJ; Jia XL; Wang YX; Zhai LH; Li DZ; Liu J; Zhang D; Chen YL; Xu YH; Lee SK; Xu GF; Chen XH; Dang YJ; Liu B; Tan MJ
Acta Pharmacol Sin; 2020 Sep; 41(9):1246-1254. PubMed ID: 32210356
[TBL] [Abstract][Full Text] [Related]
25. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
26. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein.
Isakson P; Bjørås M; Bøe SO; Simonsen A
Blood; 2010 Sep; 116(13):2324-31. PubMed ID: 20574048
[TBL] [Abstract][Full Text] [Related]
27. Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores.
Szewczyk SM; Verma I; Edwards JT; Weiss DR; Chekler ELP
J Med Chem; 2024 Jan; 67(2):1327-1335. PubMed ID: 38170610
[TBL] [Abstract][Full Text] [Related]
28. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
Zhu J; Gianni M; Kopf E; Honoré N; Chelbi-Alix M; Koken M; Quignon F; Rochette-Egly C; de Thé H
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14807-12. PubMed ID: 10611294
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.
Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S
Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799
[TBL] [Abstract][Full Text] [Related]
31. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
Tomita A; Buchholz DR; Obata K; Shi YB
J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
[TBL] [Abstract][Full Text] [Related]
32. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
33. On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations.
Weiss DR; Bortolato A; Sun Y; Cai X; Lai C; Guo S; Shi L; Shanmugasundaram V
J Chem Inf Model; 2023 Apr; 63(8):2382-2392. PubMed ID: 37037192
[TBL] [Abstract][Full Text] [Related]
34. Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug-induced thrombocytopenia.
Tochigi T; Miyamoto T; Hatakeyama K; Sakoda T; Ishihara D; Irifune H; Shima T; Kato K; Maeda T; Ito T; Handa H; Akashi K; Kikushige Y
Blood; 2020 Jun; 135(24):2146-2158. PubMed ID: 32219443
[TBL] [Abstract][Full Text] [Related]
35. TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid.
Chong ML; Cheng H; Xu P; You H; Wang M; Wang L; Ho HH
Leuk Res; 2018 Nov; 74():51-54. PubMed ID: 30292835
[No Abstract] [Full Text] [Related]
36. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
[TBL] [Abstract][Full Text] [Related]
37. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
38. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Hong SH; David G; Wong CW; Dejean A; Privalsky ML
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
[TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
Zhang XW; Yan XJ; Zhou ZR; Yang FF; Wu ZY; Sun HB; Liang WX; Song AX; Lallemand-Breitenbach V; Jeanne M; Zhang QY; Yang HY; Huang QH; Zhou GB; Tong JH; Zhang Y; Wu JH; Hu HY; de Thé H; Chen SJ; Chen Z
Science; 2010 Apr; 328(5975):240-3. PubMed ID: 20378816
[TBL] [Abstract][Full Text] [Related]
40. Cereblon modulators: Low molecular weight inducers of protein degradation.
Chamberlain PP; Cathers BE
Drug Discov Today Technol; 2019 Apr; 31():29-34. PubMed ID: 31200856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
